Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

  1. Home
  2. Homepage
Filter by
  • Filter by
  • Remove this filter Infectious disease: Respiratory diseases
  • Remove this filter Type: Expert opinion
  • Infectious disease
    • Respiratory diseases (5)
    • Vaccine preventable diseases (5)
    • Influenza (4)
    • Influenza in humans, seasonal (3)
    • Seasonal influenza (3)
    • Flu (3)
    • Zoonosis (2)
    • Influenza in humans, swine origin (2)
    • Zoonotic influenza (2)
    • Tuberculosis (1)
    • Avian influenza virus (1)
    • Influenza in humans, avian origin (1)
    • Swine-origin influenza (1)
    • Avian influenza in humans (1)
    • Influenza A (H9N2) (1)
  • Public health area
    • Scientific advice (5)
    • Prevention and control (2)
    • Disease prevention (2)
    • Prophylaxis (2)
    • Public health threat (1)
    • Vaccination coverage (1)
    • Immunisation (1)
    • Outbreak (1)
    • Vaccination (1)
    • Active immunisation (1)
    • Threats and outbreaks (1)
    • Antiviral (1)
    • Vaccine effectiveness (1)
  • Country
    • Europe (5)
  • Type
    • Expert opinion (5)
    • Publication (5)
    • Technical report (1)
    • Public consultation (1)
  • Page 1 of 1 // 5 Results found
    • Sort by:

Publication

Scientific opinion on the possible risks posed by the influenza A (H3N2v) virus for animal health and its potential spread and implications for animal and human health

Expert opinion - 17 Oct 2013

Swine are an important host in influenza virus ecology since they are susceptible to infections with both avian and human influenza A viruses.

Scientific-opinion-risk-swine-origin-influenza-A(H3N2)-EFSA-EMA.pdf - EN - [PDF-1.55 MB]
  • Europe
  • Influenza
  • Influenza in humans, swine origin
  • Public health threat
  • Scientific advice

Publication

Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA

Expert opinion - 19 Mar 2015

​This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens.

Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA - EN - [PDF-578.52 KB]
  • Europe
  • Scientific advice
  • Tuberculosis

Publication

Expert opinion on priority risk groups for influenza vaccination

Expert opinion - 28 Aug 2008

This paper identifies and describes population groups at increased risk for severe outcomes of influenza (“risk groups”) and advocates vaccination for two major groups, namely a) persons in the older age group, usually 65 years and older; and b) persons with chronic medical conditions.

Expert opinion on priority risk groups for influenza vaccination - EN - [PDF-441.97 KB]
  • EU/EEA
  • Europe
  • Immunisation
  • Influenza
  • Influenza in humans, seasonal
  • Prevention and control
  • Scientific advice
  • Vaccination coverage
  • Vaccine effectiveness

Publication

Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza (Feb 2016)

Expert opinion, Public consultation - 17 Feb 2016

A consultation with European and international public health experts was convened to review data presented in newly conducted systematic reviews and meta-analyses regarding influenza antivirals, in order to develop an ECDC Expert Opinion.

Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza - Review of recent systematic reviews and meta-analyses (Feb 2016) - EN - [PDF-719.64 KB]
  • Europe
  • Influenza
  • Influenza in humans, seasonal
  • Scientific advice

Publication

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses

Expert opinion - 14 Aug 2017

This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - EN - [PDF-1.15 MB]
  • Antiviral
  • Avian influenza virus
  • Europe
  • Influenza
  • Influenza in humans, avian origin
  • Influenza in humans, seasonal
  • Prevention and control
  • Scientific advice
  • Zoonotic influenza
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us